CT09C – “Clinical Urine Drug Abuse Screen 9C With Confirmation”

Update to specimen information, specimen requirements, methodology, and performed days.

Specimen Information:

• This test is for clinical use only and not intended for employment related testing. 
• See Interface map for a complete list of analytes included. 
• Quantitative confirmation is automatically reflexed and performed on positive screens. 
• This panel is NOT designed to detect pain drugs including buprenorphine, fentanyl, meperidine, oxycodone, and tramadol. See the PN03C panel if these tests are required.
• False negative results may occur if drugs are present below the tests limit of detection. 

Specimen Preparation: Send 30.0 mL urine in a screw capped plastic urine container.
Newborn minimum requires 1.0 mL urine and 0.5 – 5.0 mL for positive confirmations. 

Methodology: Enzyme Immunoassay; Gas Chromatography/Mass Spectrometry; Liquid Chromatography/Tandem Mass Spectrometry

Performed Days: Monday – Friday